A judge has dismissed a second defamation case against Fairfax Media brought by an associate of a murdered Sydney businessman, ruling the plaintiff waived his right to sue again after dropping an earlier suit against the publisher for a $75,000 payout.
A former RMIT worker suing the university for allegedly firing him after he blew the whistle on a colleague for selling exam answers to students has won a bid to subpoena documents from the Victorian Ombudsman.
A judge has dismissed a bid by Geneva Laboratories to add the sole director of a healthcare product distributor as a defendant in a high-stakes case over counterfeit versions of its popular and premium-priced Bio-Oil line of skin-care products.
A barrister for the Australian Writers’ Guild has blasted documents produced by the non-profit Screenrights in a court battle over tens of millions of dollars in royalties payments, calling the evidence a “complete mishmash”.
Two high ranking analysts from S&P Global have distanced themselves from the decision making process at the heart of a class action over toxic financial products given healthy ratings by the agency ahead of the global financial crisis.
The independence of a report by law firm Clayton Utz to ASIC over AMP’s practice of charging customers for services not performed was called into question Tuesday at the Hayne Royal Commission.
A judge has rejected a bid by information services company SAI Global Property to temporarily ban a former sales manager from working for a direct competitor, saying the executive could not have realistically remembered SAI’s list of thousands of clients.
Two Commonwealth Bank subsidiaries have entered an agreement with ASIC to pay $3 million for failing to provide annual reviews to customers that paid for the service, adding to the $88 million they have already paid out to 31,500 affected customers.
A BHP subsidiary has won a reprieve pending appeal of a Fair Work Commission decision that found it acted unreasonably when it failed to consider alternative work for an incapacitated miner.
The maker of the anti-depressant Lexapro faced off Monday against Apotex, Aspen Pharma and Sandoz at a court hearing over the rights to make generic versions of the top-selling product, with a barrister for Lundbeck slamming the three companies’ defence that their drugs were different.
For information on rights and reprints, contact subscriptions@lawyerly.com.au
